HSBC Innovation Expects Settled Life Science Market By End Of 2024

Insights From Former SVB Life Science Exec

Michael White, the new UK head of life sciences at HSBC Innovation Banking, made the move from California to join the UK group shortly before Silicon Valley Bank in London collapsed in March 2023. He talks to In Vivo about turbulent life science markets and the future life sciences strategy at HSBC.

Pros and cons concept. Business man with cardboard plus and minus symbol signs.
• Source: Shutterstock

A key component in the European biotech ecosystem, Silicon Valley Bank UK, was saved in March with a buyout by HSBC, Europe’s biggest bank, for just £1 ($1.2).

SVB UK, which had loans of around £5.5bn and deposits of around £6.7bn, was a key lender to the European...

More from Business Strategy

More from In Vivo

Rising Leaders 2025: Doxie Jordan, From UNC Graduate To Global Market Strategist

 
• By 

Bristol Myers Squibb executive Doxie Jordan discusses his path to global commercial leadership and the principles guiding pharmaceutical market strategy

Podcast: Brain+ CEO Discusses “Groundbreaking” Potential Of CST Assistant For Dementia Patients

 

Devika Wood, CEO of Brain+, explains the importance of developing health tech solutions for dementia and the growing need to both raise awareness and improve overall access to nondrug interventions like CST.

Behind The Buyout: Dispatches From The Dealmaking Table

 
• By 

In a challenging funding environment for biopharma, strategic dealmaking has become a critical growth engine. In Vivo explores what it truly takes to navigate high-stakes acquisitions and partnerships, drawing on insights from seasoned industry leaders.